Jasper Therapeutics to Present at 46th Annual TD Cowen Healthcare Conference Feb 24, 2026 04:30PM
Jasper Therapeutics to Present at Upcoming Investor Conferences Nov 4, 2025 08:00AM
Jasper Therapeutics prices $30 million public offering at $2.43 per share Sep 19, 2025 12:08AM
Jasper Therapeutics Announces Pricing of $30 Million Public Offering of Common Stock, Pre-Funded Warrants and Common Warrants Sep 19, 2025 12:07AM
Jasper Therapeutics announces public offering of stock and warrants Sep 18, 2025 04:08PM


Sep 18, 2025 04:08PM Jasper Therapeutics Announces Proposed Public Offering of Common Stock, Pre-Funded Warrants and Common Warrants
Jul 7, 2025 02:23PM TD Cowen Reiterates Buy Rating on Jasper Therapeutics (JSPR)
Feb 25, 2025 04:30PM Jasper Therapeutics to Present at Upcoming March Investor Conferences
Oct 14, 2024 02:17PM TD Cowen Reiterates Buy Rating on Jasper Therapeutics (JSPR)
Sep 4, 2024 04:30PM Jasper Therapeutics to Present at Present at Upcoming September Investor Conferences
Jul 10, 2024 07:38AM TD Cowen Reiterates Buy Rating on Jasper Therapeutics (JSPR)
Mar 18, 2024 05:30AM TD Cowen Starts Jasper Therapeutics (JSPR) at Outperform
Feb 26, 2024 04:30PM Jasper Therapeutics to Present at the 43rd Annual TD Cowen Healthcare Conference
Feb 6, 2024 09:00AM Jasper Therapeutics (JSPR) Announces Pricing of $50 Million Underwritten Offering of Common Stock
Feb 6, 2024 08:59AM Jasper Therapeutics Announces Pricing of $50 Million Underwritten Offering of Common Stock